Capstone Holding Corp. — Director's Dealing 2013

Oct 30, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2013-10-25

Reporting Person: TAEGER LESLIE M (SVP Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-10-25	Stock Option (Right to Buy)	$0.35	A	10000	Acquired	2023-10-25	Common Stock (10000)	Direct

Footnotes

F1: 50% to vest 10/25/2013 and 50% to vest monthly over 12 month-period